Polypoidal Choroidal Vasculopathy
Polypoidal Choroidal Vasculopathy
Explore linked clinical trials. Standard reference: MESH:M0007519486 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety | Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Venous Thrombosis, cardiovascular disorder, choroidal neovascularization, diabetic macular edema, eye disorder, optic choroid disorder, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-25 | NCT07481500 | |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Phase 3 | 2026-03-10 | NCT07461441 | |
| Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 4 | 2026-02-06 | NCT06709339 | |
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Recruiting | Phase 3 | 2026-02-05 | NCT07389980 | |
| A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder | Not yet recruiting | Phase 4 | 2026-01-26 | NCT07365371 | |
| OCT in Rare Chorioretinal Diseases | Aneurysm, Arterial Occlusive Diseases, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, cardiovascular disorder, central serous chorioretinopathy, choroidal neovascularization, eye disorder, hypertensive disorder, hypertensive retinopathy, optic choroid disorder, retinal artery occlusion, retinal disorder, uveal disorder, vascular disorder | Recruiting | Not stated | 2024-02-12 | NCT02141308 |